Target intelligence / Profile preview

KH and NYN domain-containing protein (KHNYN)

Target
KHNYN
Molecular classification
Endoribonuclease, Protein cofactor, Other: KH-like domain-containing protein
01

Overview

KHNYN (KH and NYN domain-containing protein) is a multidomain endoribonuclease that functions as a cofactor for the zinc finger antiviral protein (ZAP). The protein contains a KH-like domain (which, unlike classical KH domains, does not robustly bind RNA but may interface with other proteins) and a NYN domain that confers catalytic activity required for the degradation of viral RNA. KHNYN is essential for ZAP-mediated antiviral activity and restricts infection by viruses such as HIV and SARS-CoV-2, supporting the cellular antiviral response. Unlike canonical KH domains, the KHNYN KH domain is evolutionarily divergent and primarily serves as a protein-protein interaction site rather than an RNA-binding module. KHNYN is not currently targeted by any drugs, nor used as a biomarker or has known therapeutic safety concerns. Its disease role is mainly related to host defense against viral infection.

Other names
KHNYNKIAA0323Protein KHNYNKH and NYN domain-containing proteinCGIN1 domain-containing protein
02

Mechanism of action

Mechanism for biological function involves endonucleolytic cleavage (via NYN domain) and facilitating ZAP-mediated RNA degradation

03

Biological functions

Degradation of viral RNAAntiviral responseProtein-protein interaction site
04

Disease associations

Infection
05

Safety considerations

None currently established for therapeutic targeting.

Beyond the preview

Go deeper on KH and NYN domain-containing protein (KHNYN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KH and NYN domain-containing protein (KHNYN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call